EUVIMEDEUVIMED entdecken
EditorialKommentar

Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV ‐infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply

Chan Xie iD

Alimentary Pharmacology & Therapeutics · 2024

DOI: 10.1111/apt.18174 ↗

Kurz gefasst

Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2024. Verfasst von Chan Xie. Beteiligte Einrichtung: Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Antiviral Agents. Die Arbeit nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LINKED CONTENT This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.18131 and https://doi.org/10.1111/apt.18142

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHumansB7-H1 AntigenPolyethylene GlycolsProgrammed Cell Death 1 ReceptorInterferon-alphaHepatitis B, ChronicHepatitis B virusHepatitis B

Substanzen

Antiviral AgentsB7-H1 AntigenPolyethylene GlycolsProgrammed Cell Death 1 ReceptorInterferon-alphaCD274 protein, human

Autor:innen und Institutionen

  • Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

ORCID-Profile: Chan Xie

Zitieren

APA

Xie, C. (2024). Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV ‐infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18174

Vancouver

Xie C. Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV ‐infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.18174

BibTeX
@article{Xie2024,
  author = {Xie, Chan},
  title = {Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV ‐infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1111/apt.18174}
}
Kostenlos starten →